Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 516 Bevacizumab 487 Carboplatin 424 pembrolizumab 384 Paclitaxel 384 Gemcitabine 372 Cisplatin 366 Docetaxel 323 Rituximab 316 Radiotherapy 295 Nivolumab 247 Doxorubicin 243 Dexamethasone 239 Fluorouracil 225 Capecitabine 214 Oxaliplatin 211 Erlotinib Hydrochloride 206 fludarabine phosphate 200 Etoposide 187 Cetuximab 184 Lenalidomide 176 Pemetrexed 175 Bortezomib 174 Trastuzumab 173 Filgrastim 171 fludarabine 166 Prednisone 166 Leucovorin 166 Cytarabine 165 Irinotecan 161

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Has results × Patient Reported Outcome Measures × Clear all

NCT04272801 2025-10-22

POWER

University of Virginia

Phase 2 Active not recruiting

84 enrolled 9 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡